Gilead Price-to-Fair-Value Convergence Underway!
It’s a bird… It’s a plane… Nope, it’s Best Ideas Newsletter Portfolio holding Gilead Sciences (GILD) flying high in the months of May and June. For those that are new to the Gilead “story,” shares registered a 10 on the Valuentum Buying Index in September of last year, and while the near term has been a bit rocky, the company is now off to the races. The pharma giant was trading just over $100 at the end of April, and now, 10 days into the month of June, its share price is over $117 and climbing, a cool 17% move. Despite news being sparse on the company during the past few weeks, there are certainly a number of factors driving … Read more